亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Detecting HTERT Promoter Methylation

詳細技術說明
Telomeres are repetitive DNA structures at the ends of chromosomes that protect against chromosomal degradation and end-to-end fusion. In the absence of a mechanism to maintain telomere integrity in p
*Abstract
Telomeres are repetitive DNA structures at the ends of chromosomes that protect against chromosomal degradation and end-to-end fusion. In the absence of a mechanism to maintain telomere integrity in proliferating cells, telomere attrition can result in cell senescence or cell death. The majority of malignant tumor cells (80-90%) maintain a sufficient level of telomere integrity by aberrant activation of the enzyme telomerase. In contrast, telomerase activity is below detection levels in somatic cells and benign neoplastic cells. Expression of the catalytic and rate-limiting subunit of this enzyme, TERT, is upregulated in the majority of cancer cells; in some cases this correlates with aberrant CpG methylation of a particular region of the TERT promoter. Researchers at St. Jude have developed a cheaper and faster method for detecting a methylation signature of the TERT promoter, which has previously been shown to be useful for cancer diagnosis by Branco (WO2013/173912). This new method involves simple restriction enzyme analysis of the promoter region. Alternative detection methods, such as pyrosequencing or next-generation bisulfite sequencing, are expensive and not easily transferrable to the diagnostic platform used by clinical laboratories. This newly developed assay is simple, inexpensive, easy to interpret, reliable, and accurate and might become the method of choice for many clinical applications for cancer diagnosis in the future and for assessing tumor response to targeted demethylation therapy.
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備